4//SEC Filing
Tarka Elizabeth Ann 4
Accession 0001415889-21-001674
CIK 0000861838other
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 4:14 PM ET
Size
5.8 KB
Accession
0001415889-21-001674
Insider Transaction Report
Form 4
Tarka Elizabeth Ann
Chief Medical Officer
Transactions
- Sale
Common Stock
2021-03-25$1.35/sh−5,018$6,778→ 13,237 total
Footnotes (2)
- [F1]Restricted Stock Units ("RSUs") granted to Reporting Person on January 10, 2020 were accelerated and became fully vested on March 23, 2021. The amount reported in Column 4 represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 15,000 RSUs on March 23, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1.3501 to $1.355 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001783037
Filing Metadata
- Form type
- 4
- Filed
- Mar 28, 8:00 PM ET
- Accepted
- Mar 29, 4:14 PM ET
- Size
- 5.8 KB